Cercano Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-95,136
Closed -$7.4M 159
2024
Q4
$7.4M Sell
95,136
-670,280
-88% -$49.6M 0.19% 74
2024
Q3
$51.3M Buy
765,416
+538,166
+237% +$44.2M 1.23% 22
2024
Q2
$25.8M Buy
227,250
+8,843
+4% +$1.12M 0.69% 41
2024
Q1
$30.3M Buy
218,407
+5,339
+3% +$671K 0.84% 32
2023
Q4
$26.4M Buy
213,068
+9,108
+4% +$930K 0.87% 32
2023
Q3
$19M Buy
+203,960
New +$23M 0.68% 42
2023
Q1
Sell
-160,298
Closed -$18.2M 121
2022
Q4
$18.2M Buy
+160,298
New +$17.6M 0.74% 35

Other funds holding DXCM

Cercano Management's DXCM Position: Q1 2025 in Review

Cercano Management sold out of DexCom (DXCM) in Q1 2025, closing a stake of 95,136 shares — an estimated $7.4M sold.

Cercano Management first reported a position in DXCM in Q4 2022 and held it in 7 quarters. The position peaked at $51.3M in Q3 2024. 933 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Cercano Management reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Cercano Management sold 95,136 DexCom shares in Q1 2025, an estimated $7.4M.
  • Cercano Management first reported a position in DexCom in Q4 2022 and held it in 7 quarters.
  • Cercano Management's DexCom position peaked at $51.3M in Q3 2024.
  • 933 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Cercano Management's 13F filing for Q1 2025, filed 13 May 2025.